ANIK
ANIK develops, manufactures and commercializes therapeutic products based on hyaluronic acid (HA) used to promote the protection and healing of bone, cartilage and soft tissue. For the 6 months ended 6/30/98, revenues rose 68% to $7.4M. Net income totalled $2.8M, up from $553K. Revenues reflect increased sales of AMVISC products and ORTHOVISC. Net income also reflects an improved gross profit as a percentage of sales, and higher interest income. Anika Therapeutics, Inc.
236 West Cummings Park
Woburn, MA 01801
Phone: (781) 932-6616
Fax: (781) 935-4120
--------------------------------------------------------------------------------
Sector: Healthcare
Industry: Biotechnology & Drugs
Employees: 55
Market Cap (Mil) $ : 119.51
Complete Financials: Jun 1998
Updated: 10/17/98
Earnings Announcement:
NA
OFFICERS: D. Swann Ph.D., Chmn., J.M. Engle, Pres./CEO, S.Moran, VP-Fin./CFO/CAO/Treas., S. Kinney, VP-Ops., J. KuoPh.D., VP, E. Ross Jr., VP, M. Slater, VP. TRANSFER AGENT:First National Bank of Boston. Company inc. 1992 in MA.Direct inquiries to: Sean Moran, VP-Fin./CFO/CAO/Treas.
Key Ratios & Statistics
Price & Volume
Recent Price $ 12.00
52 Week High $ 19.13
52 Week Low $ 6.75
Avg Daily Vol (Mil) 0.07
Beta 1.42
Share Related Items
Mkt. Cap. (Mil) $ 119.51
Shares Out (Mil) 9.96
Float (Mil) 6.00
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio (TTM) % 0.00
Financial Strength
Quick Ratio (MRQ) 12.70
Current Ratio (MRQ) 14.35
LT Debt/Equity (MRQ) 0.00
Total Debt/Equity (MRQ) 0.00
Valuation Ratios
Price/Earnings (TTM) 12.54
Price/Sales (TTM) 5.85
Price/Book (MRQ) 3.97
Price/Cash Flow (TTM) 14.44
Per Share Data
Earnings (TTM) $ 0.96
Sales (TTM) $ 2.05
Book Value (MRQ) $ 3.02
Cash Flow (TTM) $ 0.83
Cash (MRQ) $ 2.37
Mgmt Effectiveness
Return on Equity (TTM) 31.19
Return on Assets (TTM) 26.36
Return on Investment (TTM) 29.26
Profitability
Gross Margin (TTM) % 63.53
Operating Margin (TTM) % 33.25
Profit Margin (TTM) % 37.70
Mil = Millions MRQ = Most Recent Quarter TTM = Trailing Twelve Months
Glossary of financial terms.
|
